75194-88-6Relevant academic research and scientific papers
Low molecular weight Myc-Max inhibitors
-
Page/Page column 9, (2008/06/13)
Compounds and compositions for interfering with the association of Myc and Max are described herein. These compounds and compositions are useful in methods inhibiting growth or proliferation of a cell. Methods of inhibiting growth or proliferation of a ce
PHAMACEUTICAL PREPARATIONS COMPRISING INSULIN
-
Page/Page column 131, (2010/02/15)
Novel preparations comprising ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer wherein the ligand is extended by protamine that are capable of prolonging the ac-tion of insulin preparations.
Stabilised insulin compositions
-
Page/Page column 55, (2008/06/13)
The present invention provides pharmaceutical compositions comprising insulin and novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The resulting preparations have improved physical and chemical stability.
PHARMACEUTICAL PREPARATIONS COMPRISING ACID-STABILISED INSULIN
-
Page/Page column 128, (2010/02/08)
Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.
Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
-
Page 42, (2010/11/30)
Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.
